ESC 365 - Impact of ESC-endorsed high ischemic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI

ACVC Premium Access

Impact of ESC-endorsed high ischemic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI

Session: ACVC Research Prize

Topic: Percutaneous Coronary Intervention (PCI)

Speaker: Doctor H. Wang (Beijing, CN)

Event: ACVC 2021

Congress Presentation

Add to my library

About the speaker

Doctor Haoyu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

3 more presentations in this session

The interplay between myocardial bridging and coronary spasm in patients with myocardial infarction and non-obstructive coronary arteries: pathogenic and prognostic implications

Speaker: Doctor R. Montone (Rome, IT)

Impella RP versus pharmacologic vasoactive treatment in profound cardiogenic shock due to right ventricular failure: Unloading and end-organ perfusion in a large animal model

Speaker: Doctor J. Josiassen (Copenhagen, DK)

Preclinical testing of a novel pericardial left ventricular assist device (PALVAD)

Speaker: Doctor A. Premawardhana (Leicester, GB)

Access the full session

ACVC Research Prize

Speakers: Doctor H. Wang, Doctor R. Montone, Doctor J. Josiassen, Doctor A. Premawardhana

About the event

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources